Patients with Community-Acquired or Health Care-Associated
Conditions
Interventions
Intervention type:
Name of intervention:
Dose form / Japanese Medical Device Nomenclature:
Route of administration / Site of application:
Dose per administration:
Dosing frequency / Frequency of use:
Sponsors
Mie University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with pneumonia Pneumonia is diagnosed on the basis of presence of clinical symptoms, laboratory finding and a new infiltrate on chest radiography.
Exclusion criteria
Exclusion criteria: Patients with acute congestive heart failure, pulmonary infarction, interstitial pneumonia or lung cancer-associated obstructive pneumonia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) To evaluate etiology and outcome of HCAP using the new argolism. 2) To compare etiology and outcome of HCAP with CAP | — |
Countries
Japan
Contacts
Public ContactTakaya Maruyama
National Hospital Organization Mie National Hospital
Outcome results
None listed